A Receptor-Mediated Pathway for Cholesterol Homeostasis

Brown, Michael S., Goldstein, Joseph L.·1986·Science
DOI 10.1126/science.3513311

Cited by (1,059)

Items 801–900 of 1,059

  1. Cellular pathology of Niemann–Pick type C disease
    Elina Ikonen, Maarit Hölttä‐Vuori · 2004 · Seminars in Cell and Developmental Biology
  2. Reduction of Blood Pressure, Plasma Cholesterol, and Atherosclerosis by Elevated Endothelial Nitric Oxide
    Rien van Haperen, Monique de Waard, Elza Dianne van Deel, Barend Mees, Michael Kutryk, Thijs van Aken, Jaap F. Hamming, Frank G. Grosveld, Dirk Jan Duncker, Rini de Crom · 2002 · Journal of Biological Chemistry
  3. The cholesterol controversy is over. Why did it take so long?
    Daniel Howard Steinberg · 1989 · Circulation
  4. Lipoprotein Lipase in the Arterial Wall
    Markku O. Pentikäinen, Riina Karoliina Oksjoki, Katariina Öörni, Petri T. Kovanen · 2002 · Arteriosclerosis Thrombosis and Vascular Biology
  5. Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor
    Hilmar Bischoff, Rolf Angerbauer, Joachim Bender, Erwin Bischoff, Agostino Faggiotto, Dieter Petzinna, Jörg Pfitzner, Michael C. Porter, Delf D. Schmidt, Günter Thomas · 1997 · Atherosclerosis
  6. Inhibition of PCSK9: A powerful weapon for achieving ideal LDL cholesterol levels
    Daniel Howard Steinberg, Joseph Lee Witztum · 2009 · Proceedings of the National Academy of Sciences
  7. RNAi-based therapeutic strategies for metabolic disease
    Michael Czech, Myriam Aouadi, Gregory J. Tesz · 2011 · Nature Reviews Endocrinology
  8. Cholesterol's location in lipid bilayers
    Drew Marquardt, Norbert Kučerka, Stephen R. Wassall, Thad A. Harroun, John Katsaras · 2016 · Chemistry and Physics of Lipids
  9. Molecular mechanism of Fast Endophilin-Mediated Endocytosis
    Alessandra Casamento, Emmanuel Boucrot · 2020 · Biochemical Journal
  10. Cellular Mechanisms of Lipid Injury in the Glomerulus
    Detlef Schlöndorff · 1993 · American Journal of Kidney Diseases
  11. The effect of taurine on cholesterol metabolism
    Wen Chen, Junxia Guo, Ping Chang · 2012 · Molecular Nutrition & Food Research
  12. Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population
    Tomi Pastinen · 1998 · Human Molecular Genetics
  13. Centripetal cholesterol flux to the liver is dictated by events in the peripheral organs and not by the plasma high density lipoprotein or apolipoprotein A-I concentration
    Christopher D. Jolley, Laura A. Woollett, Stephen D. Turley, John M. Dietschy · 1998 · Journal of Lipid Research
  14. Apolipoprotein-mediated cellular cholesterol efflux
    Shinji Yokoyama · 1998 · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
  15. Cholesterol, Atherosclerosis, and APOE in Vascular Contributions to Cognitive Impairment and Dementia (VCID): Potential Mechanisms and Therapy
    Michael Tran Duong, Ilya M. Nasrallah, David A. Wolk, Catherine C.Y. Chang, Ta‐Yuan Chang · 2021 · Frontiers in Aging Neuroscience
  16. Management of patients with familial hypercholesterolaemia
    Željko Reiner · 2015 · Nature Reviews Cardiology
  17. Genomics and Metabolomics as Markers for the Interaction of Diet and Health: Lessons from Lipids
    J. Bruce German, Matthew-Alan Roberts, Steven M. Watkins · 2003 · Journal of Nutrition
  18. Curcumin suppresses expression of low‐density lipoprotein (LDL) receptor, leading to the inhibition of LDL‐induced activation of hepatic stellate cells
    Qiaohua Kang, Anping Chen · 2009 · British Journal of Pharmacology
  19. Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice
    Cao, Dongfeng, Fukuchi, Ken-ichiro, Wan, Hongquan, Kim, Helen, Li, Ling · 2006 · Neurobiology of Aging
  20. Trafficking of Cholesterol from Cell Bodies to Distal Axons in Niemann Pick C1-deficient Neurons
    Barbara Karten, Dennis E. Vance, Robert B. Campenot, Jean E. Vance · 2003 · Journal of Biological Chemistry
  21. Two Hepatic Enhancers, HCR.1 and HCR.2, Coordinate the Liver Expression of the Entire Human Apolipoprotein E/C-I/C-IV/C-II Gene Cluster
    Charles M. Allan, Stacy Taylor, John M. Taylor · 1997 · Journal of Biological Chemistry
  22. Regulation of bovine glomerular endothelial cell growth in vitro
    Barbara J. Ballermann · 1989 · American Journal of Physiology-Cell Physiology
  23. The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland.
    Ulla‐Maija Koivisto, Hannu Turtola, Katriina Aalto‐Setälä, Bert Top, Rune R. Frants, Petri T. Kovanen, A C Syvänen, KIMMO K. KONTULA · 1992 · Journal of Clinical Investigation
  24. Familial hypercholesterolemia in Brazil: Cascade screening program, clinical and genetic aspects
    Cinthia E. Jannes, Raul Dias Santos, Pãmela R.S. Silva, Luciana Turolla, Ana Carolina Moron Gagliardi, Júlia Daher Carneiro Marsiglia, Ana Paula Marte Chacra, Marcio Hiroshi Miname, Viviane Zorzanelli Rocha, Wilson Salgado Filho et al. · 2014 · Atherosclerosis
  25. Identification of miR-185 as a regulator of de novo cholesterol biosynthesis and low density lipoprotein uptake
    Yang, Muhua, Liu, Weidong, Pellicane, Christina, Sahyoun, Christine, Joseph, Biny K., Gallo-Ebert, Christina, Donigan, Melissa, Pandya, Devanshi, Giordano, Caroline, Bata, Adam et al. · 2014 · Journal of Lipid Research
  26. The Role of Structure and Biophysical Properties in the Pleiotropic Effects of Statins
    Christopher Murphy, Evelyne Deplazes, Charles G. Cranfield, Alvaro Garcia · 2020 · International Journal of Molecular Sciences
  27. Receptor versus non-receptor mediated clearance of liposomes
    Gerrit L. Scherphof, Jan A. A. M. Kamps · 1998 · Advanced Drug Delivery Reviews
  28. Hormone-Sensitive Lipase Is Required for High-Density Lipoprotein Cholesteryl Ester-Supported Adrenal Steroidogenesis
    Fredric B. Kraemer, Wen‐Jun Shen, Kenji Harada, Shailja Patel, Jun-ichi Osuga, Shun Ishibashi, Salman Azhar · 2003 · Molecular Endocrinology
  29. Multilevel regulation of low-density lipoprotein receptor and 3-hydroxy- 3-methylglutaryl coenzyme A reductase gene expression in normal and leukemic cells
    Sigurd Vitols, Svante Norgren, Gunnar Juliusson, Loukas Tatidis, Holger Luthman · 1994 · Blood
  30. Protein folding and calcium binding defects arising from familial hypercholesterolemia mutations of the LDL receptor
    Stephen C. Blacklow, Peter S. Kim · 1996 · Nature Structural & Molecular Biology
  31. Cloning and regulation of hamster microsomal triglyceride transfer protein. The regulation is independent from that of other hepatic and intestinal proteins which participate in the transport of fatty acids and triglycerides.
    Mengjie Lin, CM Arbeeny, K. E. Bergquist, Bernadette K. Kienzle, David A. Gordon, John R. Wetterau · 1994 · Journal of Biological Chemistry
  32. Wild-type PCSK9 inhibits LDL clearance but does not affect apoB-containing lipoprotein production in mouse and cultured cells
    Lalanne, Florent, Lambert, Gilles, Amar, Marcelo J.A., Chétiveaux, Maud, Zaïr, Yassine, Jarnoux, Anne-Laure, Ouguerram, Khadija, Friburg, José, Seidah, Nabil G., Brewer, H. Bryan et al. · 2005 · Journal of Lipid Research
  33. Exome Sequencing and Directed Clinical Phenotyping Diagnose Cholesterol Ester Storage Disease Presenting as Autosomal Recessive Hypercholesterolemia
    Nathan O. Stitziel, Sigrid W. Fouchier, Barbara Sjouke, Gina Marie Peloso, Alessa M. Moscoso, Paul Livermore Auer, Anuj Goel, Bruna Gigante, Timothy A. Barnes, Olle Melander et al. · 2013 · Arteriosclerosis Thrombosis and Vascular Biology
  34. Selenium nanoparticles alleviate hyperlipidemia and vascular injury in ApoE-deficient mice by regulating cholesterol metabolism and reducing oxidative stress
    Leilei Guo, Junying Xiao, Haijuan Liu, Hongmei Liu · 2019 · Metallomics
  35. SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer' Disease: The Role of the Immune System in Clearance of Aβ from the Brain
    Delphine Boche, James A. R. Nicoll · 2008 · Brain Pathology
  36. Molecular basis of cholesterol homeostasis: lessons from Tangier disease and ABCA1
    John F. Oram · 2002 · Trends in Molecular Medicine
  37. Reducing saturated fat intake is associated with increased levels of LDL receptors on mononuclear cells in healthy men and women
    Vikkie A. Mustad, Terry D. Etherton, Allen D. Cooper, Andrea M. Mastro, Thomas A. Pearson, Satya S. Jonnalagadda, Penny M. Kris‐Etherton · 1997 · Journal of Lipid Research
  38. Reduction of serum cholesterol in Watanabe rabbits by xenogeneic hepatocellular transplantation
    J. Ryan Gunsalus, Deborah A. Brady, Sarah Coulter, Brian M. Gray, Albert S.B. Edge · 1997 · Nature Medicine
  39. Mechanisms by which saturated triacylglycerols elevate the plasma low density lipoprotein-cholesterol concentration in hamsters. Differential effects of fatty acid chain length.
    L A Woollett, David K. Spady, John M. Dietschy · 1989 · Journal of Clinical Investigation
  40. Novel loss-of-function PCSK9 variant is associated with low plasma LDL cholesterol in a French-Canadian family and with impaired processing and secretion in cell culture
    Mayne, Janice, Dewpura, Thilina, Raymond, Angela, Bernier, Lise, Cousins, Marion, Ooi, Teik Chye, Davignon, Jean, Seidah, Nabil G, Mbikay, Majambu, Chrétien, Michel · 2011 · Clinical Chemistry
  41. Dietary fiber and lipids
    T.A. Miettinen · 1987 · American Journal of Clinical Nutrition
  42. Inflammatory stress exacerbates hepatic cholesterol accumulation via increasing cholesterol uptake and de novo synthesis
    Zhao, Lei, Chen, Yaxi, Tang, Renkuan, Chen, Yao, Li, Qing, Gong, Jianping, Huang, Ailong, Varghese, Zac, Moorhead, John F, Ruan, Xiong Z · 2011 · Journal of Gastroenterology and Hepatology
  43. Lycopene in atherosclerosis prevention: An integrated scheme of the potential mechanisms of action from cell culture studies
    Paola Palozza, Nadia Parrone, Rossella E. Simone, Assunta Catalano · 2010 · Archives of Biochemistry and Biophysics
  44. Finnish type of low density lipoprotein receptor gene mutation (FH-Helsinki) deletes exons encoding the carboxy-terminal part of the receptor and creates an internalization-defective phenotype.
    Katriina Aalto‐Setälä, Eero Helve, Petri T. Kovanen, KIMMO K. KONTULA · 1989 · Journal of Clinical Investigation
  45. A whole-body mathematical model of cholesterol metabolism and its age-associated dysregulation
    Mark T. Mc Auley, Darren J. Wilkinson, Janette JL Jones, Thomas B. L. Kirkwood · 2012 · BMC Systems Biology
  46. Routes and mechanisms of post‐endosomal cholesterol trafficking: A story that never ends
    Jie Luo, Luyi Jiang, Hongyuan Yang, Bao‐Liang Song · 2017 · Traffic
  47. Endocytic and Transcytotic Processes in Villous Syncytiotrophoblast: Role in Nutrient Transport to the Human Fetus
    Renate Fuchs, Isabella Ellinger · 2004 · Traffic
  48. Perfringolysin O, a cholesterol-binding cytolysin, as a probe for lipid rafts
    Yoshiko Ohno‐Iwashita, Yukiko Shimada, A.Abdul Waheed, Masami Hayashi, Mitsushi Inomata, Megumi Nakamura, Mikako Maruya, Shintaro Iwashita · 2003 · Anaerobe
  49. Secreted proprotein convertase subtilisin/kexin type 9 reduces both hepatic and extrahepatic low-density lipoprotein receptors in vivo
    Robert J. Schmidt, Thomas P. Beyer, William R. Bensch, Yuewei Qian, Aiming Lin, Mark C. Kowala, William E. Alborn, Robert J. Konrad, Guoqing Cao · 2008 · Biochemical and Biophysical Research Communications
  50. Effect of chitosan supplementation on antitubercular drugs-induced hepatotoxicity in rats
    Sethumadhavan Santhosh, T. Sini, R. Anandan, Paruthapara Thomas Mathew · 2005 · Toxicology
  51. Chicken Oocytes and Somatic Cells Express Different Splice Variants of a Multifunctional Receptor
    Hideaki Bujo, Ken A. Lindstedt, Marcela Hermann, Lourdes Mola Dalmau, Johannes Nimpf, Wolfgang J. Schneider · 1995 · Journal of Biological Chemistry
  52. A single-base substitution in the proximal Sp1 site of the human low density lipoprotein receptor promoter as a cause of heterozygous familial hypercholesterolemia.
    Ulla‐Maija Koivisto, Jorma J. Palvimo, Olli A. Jänne, Kimmo Kontula · 1994 · Proceedings of the National Academy of Sciences
  53. Atorvastatin: An Effective Lipid-Modifying Agent in Familial Hypercholesterolemia
    Adrian David Marais, Jean Catherine Firth, Mary E. Bateman, P. J. Byrnes, Candice Martens, J. Mountney · 1997 · Arteriosclerosis Thrombosis and Vascular Biology
  54. Cloning, expression, and nucleotide sequence of rat liver sterol carrier protein 2 cDNAs.
    Udo Seedorf, Gerd Assmann · 1991 · Journal of Biological Chemistry
  55. Clinical Efficacy and Safety of Alirocumab After Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol
    Gregory G. Schwartz, Philippe Gabríel Steg, Deepak L. Bhatt, Vera Bittner, Rafael Díaz, Shaun G. Goodman, J. Wouter Jukema, Yong-Un Kim, Qian H Li, Garen Z. Manvelian et al. · 2021 · Circulation
  56. Identification of Genes Related to Growth and Lipid Deposition from Transcriptome Profiles of Pig Muscle Tissue
    Zhixiu Wang, Qinggang Li, Yangzom Chamba, Bo Zhang, Peng Shang, Hao Zhang, Changxin Wu · 2015 · PLoS ONE
  57. A CD36-related Transmembrane Protein Is Coordinated with an Intracellular Lipid-binding Protein in Selective Carotenoid Transport for Cocoon Coloration
    Takashi Sakudoh, Tetsuya Iizuka, Junko Narukawa, Hideki Sezutsu, Isao Kobayashi, Seigo Kuwazaki, Yutaka Banno, Akitoshi Kitamura, Hiromu Sugiyama, Naoko Takada et al. · 2010 · Journal of Biological Chemistry
  58. Drosophila NPC1b Promotes an Early Step in Sterol Absorption from the Midgut Epithelium
    Stephen P. Voght, Megan L. Fluegel, Laurie A. Andrews, Leo J. Pallanck · 2007 · Cell Metabolism
  59. Nuclear receptor signaling in macrophages
    Annabel F. Valledor, Mercedes Ricote · 2003 · Biochemical Pharmacology
  60. Cross-inhibition of SR-BI- and ABCA1-mediated cholesterol transport by the small molecules BLT-4 and glyburide
    Thomas J.F. Nieland, Angeliki Chroni, Michael L. Fitzgerald, Zoltan Maliga, Vassilis I. Zannis, Tomas L. Kirchhausen, Monty Krieger · 2004 · Journal of Lipid Research
  61. Mechanisms of porphyrinoid localization in tumors
    Jens Osterloh, M. Graça H. Vicente · 2002 · Journal of Porphyrins and Phthalocyanines
  62. Xanthohumol improves dysfunctional glucose and lipid metabolism in diet-induced obese C57BL/6J mice
    Cristobal L. Miranda, Valerie D. Elias, Joshua J. Hay, Jaewoo Choi, Ralph L. Reed, Jan Frederik Stevens · 2016 · Archives of Biochemistry and Biophysics
  63. Hepatic cholesterol metabolism in estrogen-treated men
    Bo Angelin, Hans Olivecrona, Eva Reihnér, Mats Rudling, Dagny Ståhlberg, Mats Eriksson, Staffan Ewerth, Peter Henriksson, Kurt Einarsson · 1992 · Gastroenterology
  64. Tocopherol distribution and intracellular localization in human adipose tissue
    Maret G. Traber, H J Kayden · 1987 · American Journal of Clinical Nutrition
  65. Changes in the spectral properties of a plasma membrane lipid analog during the first seconds of endocytosis in living cells
    C.S. Chen, Ona C. Martin, Richard E. Pagano · 1997 · Biophysical Journal
  66. Transport of maternal LDL and HDL to the fetal membranes and placenta of the Golden Syrian hamster is mediated by receptor-dependent and receptor-independent processes
    Kathleen Louise Wyne, Laura A. Woollett · 1998 · Journal of Lipid Research
  67. Very Low Density Lipoprotein (VLDL) Receptor-deficient Mice Have Reduced Lipoprotein Lipase Activity
    Yagyu, Hiroaki, Lutz, E. Peer, Kako, Yuko, Marks, Steven, Hu, Yunying, Choi, Sungshin Y., Bensadoun, Andrè, Goldberg, Ira J. · 2002 · Journal of Biological Chemistry
  68. Dietary fatty acids regulate hepatic low density lipoprotein (LDL) transport by altering LDL receptor protein and mRNA levels.
    Horton, J D, Cuthbert, J A, Spady, D K · 1993 · Journal of Clinical Investigation
  69. Pharmacology of 3‐Hydroxy‐3‐Methylglutaryl‐Coenzyme A Reductase Inhibitors (Statins), Including Rosuvastatin and Pitavastatin
    Michael Igel, Thomas Sudhop, Klaus von Bergmann · 2002 · The Journal of Clinical Pharmacology
  70. Posttraumatic epilepsy: The endophenotypes of a human model of epileptogenesis
    Ramon R. Diaz-Arrastia, Mark A. Agostini, Christopher J. Madden, Paul C. Van Ness · 2009 · Epilepsia
  71. Mechanisms for Oxidizing Low-Density Lipoprotein Insights from Patterns of Oxidation Products in the Artery Wall and from Mouse Models of Atherosclerosis
    Joseph P. Gaut · 2001 · Trends in Cardiovascular Medicine
  72. Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia
    Pernette R. W. de Sauvage Nolting, Joep C. Defesche, Rudolf J.A Buirma, Barbara A. Hutten, Peter J. Lansberg, John J.P. Kastelein · 2003 · Journal of Internal Medicine
  73. Evidence Mandating Earlier and More Aggressive Treatment of Hypercholesterolemia
    Daniel Howard Steinberg, Christopher K. Glass, Joseph Lee Witztum · 2008 · Circulation
  74. Scavenger Receptor BI (SR-BI) Clustered on Microvillar Extensions Suggests that This Plasma Membrane Domain Is a Way Station for Cholesterol Trafficking between Cells and High-Density Lipoprotein
    Yinan Peng, Wendy Akmentin, Margery A. Connelly, Sissel Lund‐Katz, Michael C. Phillips, David Lee Williams · 2003 · Molecular Biology of the Cell
  75. Distinct Endosomal Compartments in Early Trafficking of Low Density Lipoprotein-derived Cholesterol
    Shigeki Sugii, Patrick Reid, Nobutaka Ohgami, Hong Du, Ta‐Yuan Chang · 2003 · Journal of Biological Chemistry
  76. Monogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism
    Hooper, Amanda J., van Bockxmeer, Frank M., Burnett, John R. · 2005 · Critical Reviews in Clinical Laboratory Sciences
  77. Cholesterol in the year 2000
    Dennis E. Vance · 2000 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  78. Sterol-regulatory element-binding protein (SREBP)-2 contributes to polygenic hypercholesterolaemia
    André R. Miserez, Patrick Y. Muller, Luca Barella, Sandra Barella, Hannes B. Staehelin, Eran Leitersdorf, Jeremy D. Kark, Yechiel Friedlander · 2002 · Atherosclerosis
  79. Where sterols are required for endocytosis
    Harald Pichler, Howard Riezman · 2004 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  80. Differences in the Phenotypic Characteristics of Subjects With Familial Defective Apolipoprotein B-100 and Familial Hypercholesterolemia
    André R. Miserez, Ulrich Bernd Keller · 1995 · Arteriosclerosis Thrombosis and Vascular Biology
  81. Uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by low density lipoprotein receptors.
    C Koo, Mary Ellen Wernette-Hammond, Zenaida C. Garcia, Mary J. Malloy, Ricardo D. Uauy, Cara Anne East, David W. Bilheimer, Robert W. Mahley, T L Innerarity · 1988 · Journal of Clinical Investigation
  82. Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients.
    Eva Reihnér, Bo Angelin, Mats J. Rudling, Staffan Ewerth, Ingemar Björkhem, Kurt Einarsson · 1990 · Journal of Lipid Research
  83. Inhibition of HMG-CoA Reductase by Atorvastatin Decreases Both VLDL and LDL Apolipoprotein B Production in Miniature Pigs
    John R. Burnett, Lisa J. Wilcox, Dawn E. Telford, Sandra J. Kleinstiver, P. Hugh R. Barrett, Roger S. Newton, Murray W. Huff · 1997 · Arteriosclerosis Thrombosis and Vascular Biology
  84. Allosteric enhancement of ORP1-mediated cholesterol transport by PI(4,5)P2/PI(3,4)P2
    Jiangqing Dong, Ximing Du, Huan Wang, Jue Wang, Chang Lu, Xiang Chen, Zhiwen Zhu, Zhipu Luo, Li Yu, Andrew John Brown et al. · 2019 · Nature Communications
  85. Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia
    Frederick Johan Raal, Gillian J. Pilcher, D. Roger Illingworth, Anuradha S. Pappu, Evan A. Stein, Peter M. Laskarzewski, Yale Mitchel, Michael R. Melino · 1997 · Atherosclerosis
  86. Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the treatment of Type 2 diabetes and atherosclerosis
    Benoît Pourcet, Jean‐Charles Fruchart, Bart Staels, Corine Glineur · 2006 · Expert Opinion on Emerging Drugs
  87. Vascular Calcifications in Homozygote Familial Hypercholesterolemia
    Zuhier Ahmed Awan, Khalid Al‐Rasadi, Gordon A. Francis, Robert Alexander Hegele, Ruth McPherson, J. Frohlich, David A. Valenti, Benoît de Varennes, Michel Marcil, Claude Gagné et al. · 2008 · Arteriosclerosis Thrombosis and Vascular Biology
  88. The low density lipoprotein receptor is not necessary for maintaining mouse brain polyunsaturated fatty acid concentrations
    Chuck T. Chen, David W.L., John H. Kim, Howard T.J. Mount, Richard Paul Bazinet · 2007 · Journal of Lipid Research
  89. Retention of chylomicron remnants by arterial tissue; importance of an efficient clearance mechanism from plasma
    John C.L. Mamo, Spencer D. Proctor, Darrin Smith · 1998 · Atherosclerosis
  90. Recycling of Apoprotein E Is Associated with Cholesterol Efflux and High Density Lipoprotein Internalization
    Heeren, Joerg, Grewal, Thomas, Laatsch, Alexander, Rottke, Daniel, Rinninger, Franz, Enrich, Carlos, Beisiegel, Ulrike · 2003 · Journal of Biological Chemistry
  91. Cholesterol-independent Effects of Statins and New Therapeutic Targets: Ischemic Stroke and Dementia
    Miida, Takashi, Hirayama, Satoshi, Nakamura, Yuichi · 2004 · Journal of Atherosclerosis and Thrombosis
  92. Probiotic Lactobacillus rhamnosus GG and Aloe vera gel improve lipid profiles in hypercholesterolemic rats
    Manoj Kumar, Shruti Rakesh, Ravinder Nagpal, R. Hemalatha, Appana V. S. Ramakrishna, V. Sudarshan, Ramesh Ramagoni, Mohd Shujauddin, Vinod Verma, Ashok Kumar et al. · 2013 · Nutrition
  93. Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia
    Masatsune Ogura, Mika Hori, Mariko Harada‐Shiba · 2015 · Arteriosclerosis Thrombosis and Vascular Biology
  94. Soy Isoflavones Affect Sterol Regulatory Element Binding Proteins (SREBPs) and SREBP-Regulated Genes in HepG2 Cells
    Eimear Mullen, Rachel Mary Brown, Timothy F. Osborne, Neil F. Shay · 2004 · Journal of Nutrition
  95. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency.
    Katsunori Ikewaki, M Nishiwaki, T Sakamoto, T Ishikawa, Thomas Fairwell, Loren A. Zech, Makoto Nagano, Haruki Nakamura, H Bryan Brewer, Daniel James Rader · 1995 · Journal of Clinical Investigation
  96. Intracellular protein trafficking defects in human disease
    Jane F. Amara, Seng H. Cheng, Alan E. Smith · 1992 · Trends in Cell Biology
  97. Relationships of Abdominal Obesity and Hyperinsulinemia to Angiographically Assessed Coronary Artery Disease in Men With Known Mutations in the LDL Receptor Gene
    Daniel Gaudet, Marie‐Claude Vohl, Patrice Perron, Gérald Tremblay, Claude Gagné, Daniel Lesiège, Jean Bergeron, Sital Moorjani, Jean‐Pierre Després · 1998 · Circulation
  98. Mitochondrial dysfunction in patients with primary congenital insulin resistance
    Alison Sleigh, Philippa Raymond‐Barker, Kerrie Thackray, David Andrew Porter, Mensud Hatunic, Alessandra Vottero, Christine Pamela Burren, Catherine Mitchell, Martin McIntyre, Søren Brage et al. · 2011 · Journal of Clinical Investigation
  99. Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol and triacylglycerides in HepG2 cells
    Hubert Scharnagl, Renana Schinker, Hedi Gierens, Markus Nauck, Heinrich Wieland, Winfried März · 2001 · Biochemical Pharmacology
  100. Autoimmunity, oxidized LDL and cardiovascular disease
    Johan Frostegård · 2002 · Autoimmunity Reviews